Yeast treatment may affect warfarin therapy
|
Tweet
|
|
For women taking warfarin to prevent blood clots, a single dose of fluconazole to treat a vaginal yeast infection can lead to an increased risk of bleeding, findings from a small study suggest.
The time taken for blood to clot—the so-called prothrombin time—should therefore be carefully monitored in this scenario, and a change in warfarin dose may be needed, the author advises.
Fluconazole (brand name, Diflucan) is a common treatment for vaginal candidiasis, and is known to interact with a number of drugs, including warfarin—which can give rise to serious bleeding complications—according to the report in the medical journal Obstetrics and Gynecology.
While a few studies have looked at the effect of several days of fluconazole therapy on bleeding risk in warfarin users, until now none had looked at the impact of a single dose.
The study involved six women who had been on warfarin therapy for at least 6 months and had no dose changes in the last 4 weeks. Prothrombin time and other blood-clotting measurements were taken at the start of the study and then repeated 2, 5, and 8 days after the participants took one 150-milligram dose of fluconazole.
Prothrombin times increased by 11 percent, 34 percent and 2 percent at each time point, respectively, Dr. Mark A. Turrentine, from the Kelsey-Seybold Clinic in Houston, found.
Following the fluconazole dose, three of the women required a decrease in warfarin dose.
Because the difference between a dangerous dose and an effective dose of warfarin is so narrow, and given the “individual sensitivity demonstrated by a portion of the population, some alteration of the dose of warfarin may be necessary when patients are given even a single dose of fluconazole,” Turrentine concludes.
SOURCE: Obstetrics and Gynecology, February 2006.
Revision date: July 4, 2011
Last revised: by David A. Scott, M.D.
| RELATED STORIES: | ||
| Comments | [ + Post Your Own ] |
Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.
There are no comments for this entry yet. [ + Comment here + ]
We are pleased to let readers post comments about an article. Please increase the credibility of your post by including your full name and email.
All comments are reviewed by our editors before they are posted on the site. Just keep it clean, kids.




